Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Response Biomedical Announces Share Consolidation - Quick Facts

9/24/2012 6:44 PM ET

Response Biomedical Corp. (RBM.TO: Quote, RPBIF.PK) announced the completion of the consolidation of issued and outstanding common shares of the Company on the basis of every twenty Common Shares being consolidated into one Common Share.

The company said it expects the post-Consolidation Common Shares to begin trading on the Toronto Stock Exchange and the OTC Bulletin Board in the United States on or about September 26, 2012.

Click here to receive FREE breaking news email alerts for Response Biomedical Corporation and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Stocks are turning in a lackluster performance in early trading on Monday after showing a strong move to the upside last week. The major averages are showing only modest moves, lingering near the unchanged line. The major averages are currently turning in a mixed performance, with the Nasdaq just above the unchanged line. Thailand lowered its full-year growth outlook after weaker domestic demand and exports weighed on economic activity in the first three months of the year. Gross domestic product expanded 5.3 percent year-on-year in the first quarter of 2013 compared to an upwardly revised 19.1 percent growth in the fourth quarter of 2012, the National Economic and Social Development Board (NESDB) said Monday. The fifth consecutive monthly increase in the U.K. house prices amid limited supply took average asking prices to a record, a survey by Rightmove showed Monday. House prices hit a record GBP 249,841 in May, as new sellers raised their prices by 2.1 percent from the prior month. Prices were up by the same magniture in April.
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.